Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1993 Jan;61(1):253–259. doi: 10.1128/iai.61.1.253-259.1993

Neuraminidase production by a Pasteurella haemolytica A1 strain associated with bovine pneumonia.

D C Straus 1, P J Unbehagen 1, C W Purdy 1
PMCID: PMC302712  PMID: 8418046

Abstract

The properties of an extracellular neuroaminidase produced by a Pasteurella haemolytica A1 strain (isolated from a case of bovine pneumonia) during growth in a defined medium were examined in this investigation. This enzyme, isolated from concentrated culture supernatants of P. haemolytica A1, was active against N-acetylneuramin lactose, human alpha 1-acid glycoprotein, fetuin, and bovine submaxillary mucin. Neuraminidase production paralleled bacterial growth in a defined medium and was maximal in the stationary phase of growth. The enzyme was purified to homogeneity by a combination of salt fractionation, ion-exchange chromatography on DEAE-Sephacel, and gel filtration on Sephadex G-200. These procedures yielded an enzyme preparation that possessed a specific activity of 100.62 mumol of sialic acid released per min per mg of protein against human alpha 1-acid glycoprotein. The Km value for this enzyme with human alpha 1-acid glycoprotein as the substrate was 1.1 mg/ml, and the enzyme possessed a pH optimum of 6.5. The P. haemolytica A1 neuraminidase had a molecular weight of approximately 150,000 as estimated by gel filtration and approximately 170,000 when analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The enzyme was stable at 4 degrees C for 3 h. At 37 degrees C for 3 h, 25% of enzymatic activity was lost. Approximately 55% of the enzyme activity was lost within 30 min at 50 degrees C, with greater than 70% of the enzyme activity being destroyed within 10 min at temperatures of > or = 65 degrees C.

Full text

PDF
253

Images in this article

257Image
on p.257

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMINOFF D. Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem J. 1961 Nov;81:384–392. doi: 10.1042/bj0810384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cassidy J. T., Jourdian G. W., Roseman S. The sialic acids. VI. Purification and properties of sialidase from Clostridium perfringens. J Biol Chem. 1965 Sep;240(9):3501–3506. [PubMed] [Google Scholar]
  3. DAVIS B. J. DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci. 1964 Dec 28;121:404–427. doi: 10.1111/j.1749-6632.1964.tb14213.x. [DOI] [PubMed] [Google Scholar]
  4. Davis L., Baig M. M., Ayoub E. M. Properties of extracellular neuraminidase produced by group A streptococcus. Infect Immun. 1979 Jun;24(3):780–786. doi: 10.1128/iai.24.3.780-786.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Drzeniek R. Viral and bacterial neuraminidases. Curr Top Microbiol Immunol. 1972;59:35–74. doi: 10.1007/978-3-642-65444-2_2. [DOI] [PubMed] [Google Scholar]
  6. Flashner M., Wang P., Hurley J. B., Tanenbaum S. W. Properties of an inducible extracellular neuraminidase from an Arthrobacter isolate. J Bacteriol. 1977 Mar;129(3):1457–1465. doi: 10.1128/jb.129.3.1457-1465.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Frank G. H. Pasteurella haemolytica and respiratory disease in cattle. Proc Annu Meet U S Anim Health Assoc. 1979;(83):153–160. [PubMed] [Google Scholar]
  8. Frank G. H., Tabatabai L. B. Neuraminidase activity of Pasteurella haemolytica isolates. Infect Immun. 1981 Jun;32(3):1119–1122. doi: 10.1128/iai.32.3.1119-1122.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Glasgow L. R., Paulson J. C., Hill R. L. Systematic purification of five glycosidases from Streptococcus (Diplococcus) pneumoniae. J Biol Chem. 1977 Dec 10;252(23):8615–8623. [PubMed] [Google Scholar]
  10. Isacson P. Myxoviruses and autoimmunity. Prog Allergy. 1967;10:256–292. [PubMed] [Google Scholar]
  11. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  12. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  13. Lillie L. E. The bovine respiratory disease complex. Can Vet J. 1974 Sep;15(9):233–242. [PMC free article] [PubMed] [Google Scholar]
  14. Milligan T. W., Baker C. J., Straus D. C., Mattingly S. J. Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Infect Immun. 1978 Sep;21(3):738–746. doi: 10.1128/iai.21.3.738-746.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Milligan T. W., Mattingly S. J., Straus D. C. Purification and partial characterization of neuraminidase from type III group B streptococci. J Bacteriol. 1980 Oct;144(1):164–171. doi: 10.1128/jb.144.1.164-171.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Milligan T. W., Straus D. C., Mattingly S. J. Extracellular neuraminidase production by group B streptococci. Infect Immun. 1977 Oct;18(1):189–195. doi: 10.1128/iai.18.1.189-195.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Moriyama T., Barksdale L. Neuraminidase of Corynebacterium diphtheriae. J Bacteriol. 1967 Nov;94(5):1565–1581. doi: 10.1128/jb.94.5.1565-1581.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Purdy C. W., Straus D. C., Livingston C. W., Jr, Foster G. S. Immune response to pulmonary injection of Pasteurella haemolytica-impregnated agar beads followed by transthoracic challenge exposure in goats. Am J Vet Res. 1990 Oct;51(10):1629–1634. [PubMed] [Google Scholar]
  19. Ray P. K. Bacterial neuraminidase and altered immunological behavior of treated mammalian cells. Adv Appl Microbiol. 1977;21:227–267. doi: 10.1016/s0065-2164(08)70043-1. [DOI] [PubMed] [Google Scholar]
  20. Rinderknecht H., Geokas M. C., Silverman P., Haverback B. J. A new ultrasensitive method for the determination of proteolytic activity. Clin Chim Acta. 1968 Aug;21(2):197–203. doi: 10.1016/0009-8981(68)90127-7. [DOI] [PubMed] [Google Scholar]
  21. Scharmann W., Drzeniek R., Blobel H. Neuraminidase of Pasteurella multocida. Infect Immun. 1970 Mar;1(3):319–320. doi: 10.1128/iai.1.3.319-320.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Smith H. Microbial surfaces in relation to pathogenicity. Bacteriol Rev. 1977 Jun;41(2):475–500. doi: 10.1128/br.41.2.475-500.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Straus D. C., Portnoy-Duran C. Neuraminidase production by a Streptococcus sanguis strain associated with subacute bacterial endocarditis. Infect Immun. 1983 Aug;41(2):507–515. doi: 10.1128/iai.41.2.507-515.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES